P&G Hygiene and Health Care Intrinsic Value
P&G Hygiene and Health Care intrinsic value. P&G Hygiene and Health Care (PGHH) median intrinsic value is ₹2768.80 from 10 valuation models (range ₹1384–₹7286), vs current price ₹6922.00 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse P&G Hygiene and Health Care annual reports for revenue, profit, balance sheet and cash flow data.
PGHH Valuation Methods Summary — DCF, Graham Number & P/E
P&G Hygiene and Health Care intrinsic value across 10 models vs current price ₹6922.00 — upside/downside and value range per method. Analyse PGHH promoter holding to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2871.60 | ₹2297.28 - ₹3445.92 | -58.5% | EPS: ₹239.30, Sector P/E: 12x |
| Book Value Method | asset | ₹1384.40 | ₹1245.96 - ₹1522.84 | -80.0% | Book Value/Share: ₹228.48, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹2076.60 | ₹1868.94 - ₹2284.26 | -70.0% | Revenue/Share: ₹1300.30, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹2768.80 | ₹2491.92 - ₹3045.68 | -60.0% | EBITDA: ₹1102.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹3489.11 | ₹2791.29 - ₹4186.93 | -49.6% | CF Growth: 12.7%, Discount: 15% |
| PEG Ratio Method | growth | ₹2076.60 | ₹1868.94 - ₹2284.26 | -70.0% | EPS Growth: 3.5%, Fair P/E: 2.8x |
| Growth Adjusted P/E | growth | ₹2076.60 | ₹1868.94 - ₹2284.26 | -70.0% | Revenue Growth: 2.0%, Adj P/E: 8.1x |
| ROE Based Valuation | profitability | ₹3767.27 | ₹3390.54 - ₹4144.00 | -45.6% | ROE: 103.1%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹2076.60 | ₹1868.94 - ₹2284.26 | -70.0% | EPS: ₹239.30, BVPS: ₹228.48 |
| Dividend Yield Method | dividend | ₹7285.71 | ₹6557.14 - ₹8014.28 | +5.3% | DPS: ₹255.00, Target Yield: 3.5% |
PGHH Intrinsic Value vs Market Price — All Valuation Models
P&G Hygiene and Health Care fair value range ₹1384–₹7286 vs current market price ₹6922.00 across 10 valuation models. For current market price and key ratios, visit P&G Hygiene and Health Care screener.
PGHH Intrinsic Value Analysis — Undervalued or Overvalued?
P&G Hygiene and Health Care median intrinsic value ₹2768.80, current price ₹6922.00 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of PGHH?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of P&G Hygiene and Health Care (PGHH) is ₹2768.80 (median value). With the current market price of ₹6922.00, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹1384.40 to ₹7285.71, indicating ₹1384.40 - ₹7285.71.
Is PGHH undervalued or overvalued?
Based on our multi-method analysis, P&G Hygiene and Health Care (PGHH) appears to be trading above calculated value by approximately 60.0%.
PGHH Financial Health — Key Ratios vs Industry Benchmarks
P&G Hygiene and Health Care financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 103.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 24.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.38x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
PGHH Cash Flow Quality — Operating & Free Cash Flow
P&G Hygiene and Health Care operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹924 Cr | ₹924 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹598 Cr | ₹581 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹470 Cr | ₹470 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹826 Cr | ₹821 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹573 Cr | ₹560 Cr | Positive Free Cash Flow | 8/10 |